Company intelligence / Profile preview

Profex

Shanghai, Shanghai, China

Ownership: Private
Employees: ~500
Development stage: Other

Overview

Profex is a leading specialty pharmaceutical and healthcare company focused on the dermatology and medical aesthetics market in China. Founded in 2001, the company specializes in the commercialization of high-quality international skin care and dermatological products. Profex provides a comprehensive platform including R&D, regulatory affairs, marketing, and multi-channel distribution. Their portfolio includes well-known brands such as Mustela and Bioderma, alongside proprietary developments in the aesthetic space.

Therapeutic areas: Dermatology
Modalities: Small moleculeTopicalBiologic
Industry: Biotech

Partnerships

Laboratoires ExpanscienceNAOSGalderma

Beyond the preview

Go deeper on Profex.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Profex.

Explore the full profile